Ignite Creation Date:
2024-05-06 @ 3:06 AM
Last Modification Date:
2024-10-26 @ 11:28 AM
Study NCT ID:
NCT02204475
Status:
WITHDRAWN
Last Update Posted:
2015-10-14
First Post:
2014-07-28
Brief Title:
Grazoprevir MK-5172Elbasvir MK-8742 Versus BoceprevirPegylated InterferonRibavarin for Chronic Hepatitis C Infection MK-5172-066
Sponsor:
Merck Sharp Dohme LLC
Organization:
Merck Sharp Dohme LLC
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-11
Start Date Type:
None
Primary Completion Date:
2016-06
Primary Completion Date Type:
ESTIMATED
Completion Date:
2016-09
Completion Date Type:
ESTIMATED
First Submit Date:
2014-07-28
First Submit QC Date:
July 28 2014
Study First Post Date:
2014-07-30
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-10-13
Last Update Post Date:
2015-10-14
Last Update Post Date Type:
ESTIMATED